Chancellor Reeves Plans Focused Action on Household Expenses in Upcoming Financial Plan
Treasury head Reeves has revealed she is planning "targeted measures to deal with household expense issues" in the upcoming financial statement.
During an interview with media outlets, she stated that lowering price rises is a joint duty of both the administration and the Bank of England.
The UK's inflation rate is forecast to be the most elevated among the Group of Seven advanced economies this calendar year and next.
Potential Utility Bill Interventions
Sources suggest the administration could take action to lower utility costs, for example by reducing the present 5% rate of VAT applied on energy.
A further approach is to cut some of the policy costs presently added to household expenses.
Budgetary Constraints and Expert Expectations
The government will receive the latest draft from the official forecaster, the Office for Budget Responsibility, on Monday, which will clarify how much scope there is for these actions.
The view from the majority of experts is that Reeves will have to introduce higher taxes or budget cuts in order to fulfill her declared fiscal targets.
Earlier on the same day, analysis indicated there was a £22bn deficit for the Treasury chief to fill, which is at the lower end of projections.
"It is a joint task between the Bank of England and the administration to bear down further on some of the drivers of price increases," the Chancellor stated to reporters in the US capital, at the yearly gatherings of the IMF and global financial institution.
Revenue Pledges and Global Issues
While much of the attention has been on expected tax rises, the Treasury chief said the latest data from the fiscal watchdog had not altered her vow to manifesto promises not to raise tax levels on earnings tax, VAT or National Insurance.
She attributed an "uncertain global environment" with rising international and commercial issues for the fiscal tax moves, probably to be directed on those "most able to pay."
International Economic Tensions
Commenting on worries about the UK's economic relations with China she said: "Our security interests invariably come first."
Recent declaration by China to strengthen trade restrictions on rare earths and other resources that are key for high-technology production led American leader the US President to threaten an extra 100% tariff on goods from the Asian country, increasing the possibility of an all-out trade war between the two global powers.
The American finance chief called the Chinese move "commercial pressure" and "a global supply chain power grab."
Inquired about considering the American proposal to participate in its conflict with the Asian nation, Reeves said she was "deeply worried" by China's actions and urged the Chinese government "not to put up barriers and limit trade."
She said the move was "harmful for the world economy and creates further challenges."
"It is my opinion there are areas where we should address Chinese policies, but there are also significant chances to export to China's economy, including banking sector and other sectors of the economic system. We've got to achieve that equilibrium right."
The chancellor also stated she was collaborating with international partners "on our own critical minerals approach, so that we are less reliant."
NHS Medicine Pricing and Investment
Reeves also acknowledged that the price the National Health Service pays for pharmaceuticals could go up as a consequence of ongoing talks with the US government and its drugs companies, in exchange for reduced taxes and funding.
A number of the biggest global pharmaceutical manufacturers have said in recent statements that they are either delaying or scrapping investments in the UK, with several blaming the modest returns they are obtaining.
Recently, the government science advisor said the price the NHS pays for drugs would need to increase to prevent firms and drug research funding leaving the UK.
The Chancellor told the BBC: "We have seen because of the payment system, that drug testing, new drugs have not been available in the UK in the extent that they are in other EU nations."
"We want to make sure that individuals getting care from the National Health Service are can access the best critical medicines in the world. And so we are looking at all of that, and... aiming to attract additional funding into Britain."